Purpose of the Test
- Accurate molecular subtyping of the tumor
- Predicting response to radiation or chemotherapy
- Screening for hereditary Lynch syndrome via MMR proteins
Book Endometrial IHC Test in Saudi Arabia | Lahalak Medical Platform
Advanced IHC staining accurately subtypes endometrial carcinoma, enabling physicians to tailor personalized adjuvant therapies and improve clinical outcomes through precise molecular profiling and protein expression analysis.
Scientific name: Immunohistochemistry (IHC) for Endometrial Carcinoma
Advanced histopathological test utilizing specific markers (p53, PTEN, MMR proteins) to subtype endometrial adenocarcinoma. It provides critical prognostic information and guides personalized adjuvant treatment strategies.
Service type
Histopathology and Lab Test
Duration
5-7 working days
Fasting
Fasting is not required
Included Services
- p53 staining
- MMR proteins screening
- PTEN staining
- Detailed pathology report
Medical Service Information
Targeted Biomarkers
- p53 Protein: To identify high-risk serous-like features
- PTEN Protein: To evaluate cell growth pathways
- MMR Proteins: To assess DNA mismatch repair status
When is this test required?
- Following a hysterectomy or endometrial biopsy
- To guide decisions regarding adjuvant therapy
- For patients diagnosed with endometrial adenocarcinoma
Conditions & Notices
- Requires a formalin-fixed tissue biopsy sample
- Initial medical report must be provided
Medical services you might also like
